Diseases, Conditions, Syndromes

Ebola vaccine to begin human trials

The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers—with the first vaccinations having already taken place.

Vaccination

WHO looking forward to oral, nasal COVID vaccines

The World Health Organization's chief scientist said Tuesday she was looking forward to the "second generation" of COVID-19 vaccines, which could include nasal sprays and oral versions.

Vaccination

Covaxin approval requested in US for ages 2-18

US company Ocugen announced Friday that it had asked authorities for emergency use authorization for COVID-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

page 22 from 40